Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary 2/13/21 Analysis and Commentary 2/13/21 FDA-related Provision of House Reconciliation Bill Read More Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Analysis and Commentary 12/10/20 Analysis and Commentary 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More Advocacy at a Glance 12/10/20 Advocacy at a Glance 12/10/20 Advocacy at a Glance Read More Analysis and Commentary 10/9/20 Analysis and Commentary 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More Advocacy at a Glance 10/9/20 Advocacy at a Glance 10/9/20 Advocacy at a Glance Read More Advocacy at a Glance 10/1/20 Advocacy at a Glance 10/1/20 Advocacy at a Glance Read More Advocacy at a Glance 9/18/20 Advocacy at a Glance 9/18/20 Advocacy at a Glance Read More Advocacy at a Glance 8/14/20 Advocacy at a Glance 8/14/20 Advocacy at a Glance Read More Advocacy at a Glance 8/7/20 Advocacy at a Glance 8/7/20 Advocacy at a Glance Read More Advocacy at a Glance 7/18/20 Advocacy at a Glance 7/18/20 Advocacy at a Glance Read More Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More Advocacy at a Glance 6/19/20 Advocacy at a Glance 6/19/20 Advocacy at a Glance Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary 2/13/21 Analysis and Commentary 2/13/21 FDA-related Provision of House Reconciliation Bill Read More
Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Analysis and Commentary 12/10/20 Analysis and Commentary 12/10/20 COVID-19 Vaccine Update: A Briefing from the FDA Read More
Analysis and Commentary 10/9/20 Analysis and Commentary 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More
Analysis and Commentary 7/10/20 Analysis and Commentary 7/10/20 CBER Director on COVID-19 and Vaccine Development Read More
